Fresh Tracks Therapeutics, Inc.
FRTXDelisted Dec 27, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000819050
Fresh Tracks Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Jun 11, 2024; 15 institutions reported holding it in 13F filings for Q3 2023, worth $455.8K in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Fresh Tracks Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −1 vs. Q3 2022
- Shares held
- 152.4K
- −69.8K (−31.4%) vs. Q3 2022
- Total value
- $224.1K
- −$103.9K (−31.7%) vs. Q3 2022
- New holders
- 2
- 3 more added
- Sold out
- 3
- 5 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $40 |
| Q4 2023 | 1 | $1.00K |
| Q3 2023 | 15 | $455.8K |
| Q2 2023 | 15 | $69.8K |
| Q1 2023 | 18 | $97.3K |
| Q4 2022 | 16 | $224.1K |
| Q3 2022 | 17 | $328.0K |
| Q2 2022 | 25 | $898.9K |
| Q1 2022 | 25 | $2.44M |
| Q4 2021 | 34 | $2.69M |
| Q3 2021 | 30 | $5.53M |
| Q2 2021 | 35 | $7.15M |
| Q1 2021 | 32 | $6.08M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Fresh Tracks Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 43 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 6 | $0 | 0.00% | +6 | New |
| Morgan Stanley | 1 | $2 | 0.00% | −869−99.9% | Reduced |
| Bank of America Corp | 5 | $8 | 0.00% | 00.0% | Unchanged |
| JFS Wealth Advisors, LLC | 22 | $33 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 118 | $177 | 0.00% | +1+0.9% | Added |
| UBS Group AG | 624 | $936 | 0.00% | +347+125.3% | Added |
| Steward Partners Investment Advisory, LLC | 709 | $1.06K | 0.00% | −99−12.3% | Reduced |
| Ronald Blue Trust, Inc. | 916 | $2.00K | 0.00% | −40,327−97.8% | Reduced |
| BlackRock Inc. | 4,790 | $7.19K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,285 | $9.00K | 0.00% | +2,925+87.1% | Added |
| Silverarc Capital Management, LLC | 10,000 | $15.0K | 0.01% | +10,000 | New |
| Geode Capital Management, LLC | 14,849 | $21.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 21,224 | $31.0K | 0.00% | −7,506−26.1% | Reduced |
| Vanguard Group Inc | 27,779 | $41.7K | 0.00% | 00.0% | Unchanged |
| Telemetry Investments, L.L.C. | 65,000 | $95.0K | 0.22% | −1,000−1.5% | Reduced |
| Palisade Capital Management LLC | 0 | $0 | 0.00% | −22,233−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,865−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −160−100.0% | Sold out |